RTI Biologics Announces Launch Of Fresh-Stored Osteochondral Allograft

RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announces the launch of its fresh-stored osteochondral (OC) allograft line at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco this week. Fresh-stored OC allografts provide mature hyaline cartilage with subchondral bone for resurfacing articular cartilage damage in the knee.

More: continued here

Filed under: Bones on March 15th, 2008